Cornerstone Investment Partners, LLC Abb Vie Inc. Transaction History

Cornerstone Investment Partners, LLC

$1.91 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $894,254 - $1.14 Million	-6,498 Reduced 49.96%	6,509 $997,000
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $487,006 - $604,237	-3,690 Reduced 22.1%	13,007 $2.11 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $586,567 - $742,177	-5,460 Reduced 24.64%	16,697 $2.26 Million
Q3 2021 Oct 25, 2021	SELL	$106.4 - $120.78 $118,104 - $134,065	-1,110 Reduced 4.77%	22,157 $2.39 Million
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $149,358 - $164,425	1,460 Added 6.7%	23,267 $2.52 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $171,820 - $201,660	2,000 Added 10.1%	21,807 $1.91 Million
Q2 2020 Jul 30, 2020	SELL	$73.37 - $98.18 $273,156 - $365,524	-3,723 Reduced 15.82%	19,807 $1.95 Million
Q1 2020 Apr 27, 2020	BUY	$64.5 - $97.79 $79,980 - $121,259	1,240 Added 5.56%	23,530 $1.79 Million
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $169,177 - $216,248	2,575 Added 13.06%	22,290 $1.62 Million
Q1 2019 Apr 26, 2019	BUY	$77.14 - $90.79 $108,767 - $128,013	1,410 Added 7.7%	19,715 $1.59 Million
Q4 2018 Jan 11, 2019	BUY	$77.85 - $96.01 $129,620 - $159,856	1,665 Added 10.01%	18,305 $1.69 Million
Q1 2018 Apr 04, 2018	BUY	$92.01 - $123.21 $83,269 - $111,505	905 Added 5.75%	16,640 $1.58 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $1.41 Million - $1.55 Million	-15,735 Reduced 50.0%	15,735 $1.52 Million
Q4 2017 Jan 22, 2018	BUY	$89.56 - $98.21 $1.41 Million - $1.55 Million	15,735 Added 100.0%	31,470 $3.04 Million
Q3 2017 Nov 08, 2017	SELL	$69.85 - $89.22 $1.1 Million - $1.4 Million	-15,735 Reduced 50.0%	15,735 $1.4 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $2.2 Million - $2.81 Million	31,470	31,470 $0

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.

Account